What is C-reactive protein?
C-reactive protein (CRP) is a significant biomarker often used in medical settings to assess inflammation and monitor the status of various health conditions. First discovered in 1930 by Tillett and Francis, CRP was named for its reaction with the C-polysaccharide of pneumococcus, indicating its presence during acute inflammatory states (Nehring et al., 2023).
Produced by the liver and responding to factors like interleukin-6 (IL-6), CRP levels elevate in the blood in response to inflammation, making it a crucial marker in diagnosing and managing conditions such as acute bacterial infections, autoimmune diseases, and chronic diseases.
Functionally, CRP is a pentameric protein that plays a dual role both as a proinflammatory and anti-inflammatory agent (Sproston & Ashworth, 2018). It assists the body's immune response by binding to phosphocholine on dead or dying cells and some types of bacteria, facilitating their clearance by phagocytic cells. This activation helps regulate the immune system's response to pathogens and damaged cells by activating the complement system and enhancing phagocytosis. However, elevated CRP levels, especially high-sensitivity CRP (hs-CRP), are linked to an increased risk of heart disease, as they might indicate ongoing inflammation that could lead to cardiovascular damage.










